Table 7.

HIV-1 Neutralization in Intact and Ig-Depleted Serum/Plasma Samples

Patient Code	HIV-1SF162				HIV-1NL4.3				HIV-1YU2
	S/Pa	IgA-Db	IgG-D	(IgA+IgG)-D	S/P	IgA-D	IgG-D	(IgA+IgG)-D	S/P	IgA-D	IgG-D	(IgA+IgG)-D
HAAL	25,331	4,645	846	20	2,416	1,695	<20	<20	1,703	2,068	<20	<20
CRNA	4,220	2,256	537	<40	722	400	20	<20	134	84	<20	<20
DASH1c	5,773	2,587	ND	<20	80	209	ND	<20	<20	<20	ND	<20
DASH2c	6,457	ND	98	<20	157	ND	<20	<20	135	ND	68	<20
DUTA	10,748	5,671	69	<40	359	227	<20	<20	262	46	<20	<20
FOBId	3,194	1,933	1,638	1,056	11,972	2,388	5,534	1,846	2,937	2,004	1,622	1,268
HALE	2,922	1,205	846	<20	357	117	<20	<20	194	<20	<20	<20
HUCA	35,469	20,996	8,628	4,037	527	805	68	<20	79	21	<20	<20
JOOL	15,350	10,178	40	<40	332	537	126	<20	443	381	<20	<20
KEMA	10,168	3,189	<40	<40	<20	37	<20	<20	944	945	<20	<20
WARO	146,312	44,937	271	<40	713	676	<40	<40	149	<40	<40	<40
THTO	2,829	2,384	<40	<40	119	121	<20	<20	<20	<20	<20	<20
MIURd	18,828	13,902	2,966	927	6,151	4,260	4,183	1,247	3,937	2,525	2,831	852
JOTA	5,512	4,288	<40	<40	819	551	<20	<20	377	176	<20	<20
JOMEd	2,520	686	310	86	1,196	951	329	217	761	480	460	190
PEDO	2,506	2,819	40	<40	205	331	<20	<20	333	238	224	25
JODEd	120,330	37,419	3,314	730	12,884	4,893	4,275	1,298	4,347	1,686	2,065	514
HUTA	2,830	935	868	<40	799	911	277	237	354	190	125	44
GRLI	984	427	<40	<40	<20	<20	<20	<20	<20	<20	<20	<20
SIDA	5,266	3,356	615	<40	439	201	69	37	72	74	80	24

^aS/P=serum/plasma.

^bIgX-D represented IgA, IgG, or both depleted from serum/plasma samples.

^cPlasma samples from DASH were collected twice, 7 months apart.

^dART patients.